pancreatic adenocarcinoma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

pancreatic adenocarcinoma
Apr 1, 2025, 11:25 | Science
Arndt Vogel: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and…
Mar 18, 2025, 18:16 | Insight
FDA grants accelerated approval to Zenocutuzumab-zbco - The Babak Lab
The Babak Lab shared a post on LinkedIn: "FDA Grants Accelerated Approval to Zenocutuzumab-zbco (Bizengri).…
Jan 27, 2025, 17:30 | Science
Five papers suggested by Arndt Vogel
Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and…
Jan 20, 2025, 12:26 | Blog
The first seminar of 2025 NCI Rising Scholars: Cancer Research Seminar Series
Train at NCI posted on LinkedIn: "Please join us for the 2025 National Cancer Institute…
Jan 13, 2025, 12:36 | Science
Elvina Almuradova: Effect of KRAS mutations on survival outcomes in metastatic pancreatic cancer
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, posted on LinkedIn…
Jan 6, 2025, 12:40 | Science
Chaitanya Bandlamudi: Detailed clinico-genomic landscape of pancreatic adenocarcinomas
Chaitanya Bandlamudi, Assistant Member at MSK Department of Pathology and Laboratory Medicine, shared a post…
Dec 12, 2024, 13:14 | Blog
Razelle Kurzrock: Targeting NRg1 fusions
Razelle Kurzrock, Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center,…
Dec 8, 2024, 04:12 | Insight
Iván González: The ESPAC4 study reveals promising results in treating pancreatic adenocarcinoma
Iván González, Medical Oncologist at the Comprehensive Oncology Center of the Hospital Ángeles Puebla, shared…
Dec 5, 2024, 11:01 | Insight
FDA Grants Accelerated Approval to Zenocutuzumab-zbco for NSCLC and Pancreatic Adenocarcinoma
On December 4, 2024, the U.S. Food and Drug Administration (FDA) granted accelerated approval for…
Nov 10, 2024, 14:58 | Blog
Pancreatic adenocarcinoma to develop unique mitochondrial subpopulations under stress
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared following post on LinkedIn: ''Study…
Nov 10, 2024, 03:56 | Insight
Routine imaging in post-operational PDAC vs symptomatic FU
A recent paper by Paul Andel, PhD-candidate of the Surgical Department at UMC Utrecht, was…
Nov 5, 2024, 11:14 | Insight
Eileen M. O’Reilly: Adjuvant mFOLFIRINOX for Resected Pancreatic Adenocarcinoma
Eileen M. O’Reilly, Oncologist at Memorial Sloan Kettering Cancer Centre, shared on X: “Adjuvant mFOLFIRINOX…
Oct 29, 2024, 09:39 | Insight
Anirban Maitra: Adjuvant Modified FOLFIRINOX for Resected Pancreatic Adenocarcinoma (PDAC) led by Eileen M O’Reilly
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared…
Sep 29, 2024, 13:56 | Blog
Medigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021
Medigene AG, an oncology platform company focused on the research and development of T cell…
Sep 18, 2024, 12:30 | Blog
Mark Lewis: RAS(ON) inhibitor responses in pancreatic adenocarcinoma
Mark Lewis posted the following on X: “Per Ignacio Garrido-Laguna, RMC-6236, a RAS(ON) multiselective inhibitor,…
Jul 20, 2024, 21:00 | Blog
Nelson Dusetti: We are grateful to INCa for funding our project - NeoPREDICT
Nelson Dusetti shared a post on LinkedIn:  . "We are grateful to INCa for funding…
Jun 9, 2024, 14:57 | Blog
No survival advantage for first-line liposomal irinotecan patients with pancreatic adenocarcinoma
Mark Lewis shared on X: "Important abstract (GIANT, or EA2186) from ASCO24 which does NOT show…
May 20, 2024, 14:44 | Blog
Syed A. Ahmad: Our review on neoadjuvant and adjuvant therapy for resectable pancreas cancer
Syed A. Ahmad, Director at University of Cincinnati Cancer Center & Chief of Surgical Oncology…
Apr 25, 2024, 18:50 | Insight
Wafik S. El-Deiry: Very pleased to share bioRxiv pre-print by El-Deiry Lab member and Brown University alumnus William MacDonald
Wafik S. El-Deiry, Director of the Legorreta Cancer Center at Brown University, shared on X:…
All: 19 Posts: 1 - 100
Special Coverage